HK Stock MarketDetailed Quotes
02126 JW THERAP-B
- 1.290
- -0.010-0.77%
Market Closed Dec 27 16:08 CST
535.93MMarket Cap-0.78P/E (TTM)
1.320High1.240Low601.38KVolume1.300Open1.300Pre Close765.19KTurnover0.15%Turnover RatioLossP/E (Static)415.45MShares2.68052wk High0.33P/B535.93MFloat Cap1.19052wk Low--Dividend TTM415.45MShs Float52.800Historical High--Dividend LFY6.15%Amplitude1.190Historical Low1.272Avg Price500Lot Size--Div YieldTTM--Div Yield LFY
JW THERAP-B Key Stats
All
YOY
| (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | 9.23%-768M | ---- | -20.48%-846.14M | ---- | 57.79%-702.33M | ---- | -162.74%-1.66B | ---- | -132.29%-633.26M |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | -121.70%-21.61M | ---- | -73.95%-9.75M | ---- | -109.81%-5.6M | ---- | -469.51%-2.67M | ---- | ---469K |
| Impairment and provisions: | ---- | --181.21M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Other impairments and provisions | ---- | --181.21M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Revaluation surplus: | ---- | ---- | ---- | ---- | ---- | -103.98%-49.06M | ---- | 187.51%1.23B | ---- | 170.59%429.05M |
| -Other fair value changes | ---- | ---- | ---- | ---- | ---- | -103.98%-49.06M | ---- | 187.51%1.23B | ---- | 170.59%429.05M |
| Asset sale loss (gain): | ---- | 452.98%929K | ---- | 40.00%168K | ---- | --120K | ---- | ---- | ---- | --67K |
| -Loss (gain) on sale of property, machinery and equipment | ---- | 452.98%929K | ---- | 40.00%168K | ---- | --120K | ---- | ---- | ---- | --67K |
| Depreciation and amortization: | ---- | 14.65%99.83M | ---- | 80.56%87.07M | ---- | 104.43%48.23M | ---- | 36.33%23.59M | ---- | 238.68%17.3M |
| -Depreciation | ---- | 16.76%82.1M | ---- | 64.42%70.31M | ---- | 84.58%42.76M | ---- | 35.82%23.17M | ---- | 236.05%17.06M |
| -Other depreciation and amortization | ---- | 5.80%17.74M | ---- | 206.96%16.76M | ---- | 1,194.08%5.46M | ---- | 72.24%422K | ---- | 642.42%245K |
| Exchange Loss (gain) | ---- | -76.46%37.32M | ---- | --158.54M | ---- | ---- | ---- | ---- | ---- | ---- |
| Special items | ---- | -57.62%34.97M | ---- | -7.68%82.5M | ---- | -30.31%89.37M | ---- | 730.37%128.23M | ---- | --15.44M |
| Operating profit before the change of operating capital | ---- | 17.49%-435.35M | ---- | 14.80%-527.6M | ---- | -120.29%-619.28M | ---- | -63.57%-281.12M | ---- | -60.44%-171.87M |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | 161.45%5.38M | ---- | 69.58%-8.76M | ---- | -2,914.03%-28.78M | ---- | ---955K | ---- | ---- |
| Accounts receivable (increase)decrease | ---- | 200.00%5.31M | ---- | ---5.31M | ---- | ---- | ---- | ---- | ---- | ---- |
| Accounts payable increase (decrease) | ---- | 46.47%-7.57M | ---- | -119.72%-14.13M | ---- | 359.34%71.67M | ---- | 2,240.19%15.6M | ---- | -117.12%-729K |
| prepayments (increase)decrease | ---- | 153.03%5.68M | ---- | -18.57%-10.72M | ---- | -138.62%-9.04M | ---- | 1,468.83%23.41M | ---- | -154.72%-1.71M |
| Special items for working capital changes | ---- | -140.64%-5.62M | ---- | -13.32%13.82M | ---- | 174.56%15.94M | ---- | -30.10%-21.38M | ---- | -116.89%-16.44M |
| Cash from business operations | 20.30%-201.5M | 21.81%-432.16M | 32.75%-252.83M | 2.95%-552.69M | -32.83%-375.98M | -115.35%-569.49M | -164.53%-283.05M | -38.64%-264.45M | -3.01%-107M | -77.74%-190.74M |
| Interest received - operating | -10.16%13.3M | 111.25%33.74M | 181.16%14.8M | 92.53%15.97M | 172.23%5.27M | 141.09%8.3M | 1,434.92%1.93M | 89.07%3.44M | -18.71%126K | 66.67%1.82M |
| Net cash from operations | 20.93%-188.2M | 25.77%-398.42M | 35.79%-238.03M | 4.36%-536.72M | -31.87%-370.72M | -115.01%-561.2M | -163.03%-281.12M | -38.15%-261.01M | -3.04%-106.88M | -77.85%-188.92M |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | ---- | ---- | --848K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Loan receivable (increase) decrease | ---- | 200.00%23.55M | ---- | ---23.55M | ---23.55M | ---- | ---- | ---- | ---- | ---- |
| Decrease in deposits (increase) | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---3.49M |
| Sale of fixed assets | ---- | 61.54%84K | ---- | --52K | ---- | ---- | ---- | ---- | ---- | ---- |
| Purchase of fixed assets | 57.57%-2.87M | 83.86%-12.41M | 74.94%-6.76M | -5.18%-76.87M | 27.23%-26.97M | 41.17%-73.09M | 52.26%-37.07M | -21.87%-124.24M | -320.19%-77.64M | -133.57%-101.95M |
| Purchase of intangible assets | -8,158.20%-10.08M | 90.84%-2.17M | 91.49%-122K | 62.98%-23.71M | 97.39%-1.43M | -972.39%-64.04M | -2,231.36%-54.86M | 50.73%-5.97M | -134.36%-2.35M | -2,319.16%-12.12M |
| Acquisition of subsidiaries | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --45.31M | --45.31M | ---- |
| Cash on investment | ---- | ---- | ---- | ---- | ---30M | ---- | ---- | ---7.01M | ---7.01M | ---- |
| Other items in the investment business | ---- | --848K | --23.55M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Net cash from investment operations | -173.89%-12.94M | 107.98%9.9M | 121.37%17.52M | 9.51%-124.08M | 10.84%-81.96M | -49.20%-137.13M | -120.47%-91.92M | 21.82%-91.91M | -114.01%-41.69M | -166.27%-117.55M |
| Net cash before financing | 8.78%-201.15M | 41.21%-388.51M | 51.29%-220.51M | 5.37%-660.81M | -21.35%-452.68M | -97.87%-698.33M | -151.09%-373.04M | -15.15%-352.91M | -20.59%-148.57M | -103.81%-306.48M |
| Cash flow from financing activities | ||||||||||
| New borrowing | 3.85%135M | -10.56%210M | --130M | --234.8M | ---- | ---- | ---- | -3.24%49.18M | --49.18M | 405.50%50.82M |
| Refund | -132.36%-63.9M | -82.30%-182.3M | -1,000.00%-27.5M | ---100M | ---2.5M | ---- | ---- | ---- | ---- | ---40.05M |
| Issuing shares | 892.59%268K | -71.28%27K | -71.58%27K | -86.51%94K | -93.12%95K | -99.98%697K | -99.81%1.38M | 662.24%2.85B | 89.70%709.13M | 32.70%373.81M |
| Interest paid - financing | -7.90%-6.02M | -82.92%-12.42M | -105.64%-5.58M | -14.86%-6.79M | 5.96%-2.72M | -12.75%-5.91M | -25.58%-2.89M | -215.15%-5.24M | -160.07%-2.3M | 42.99%-1.66M |
| Issuance expenses and redemption of securities expenses | ---- | ---- | ---- | ---- | ---- | 29.04%-15.65M | -1,898.85%-15.65M | ---22.06M | ---783K | ---- |
| Other items of the financing business | ---- | ---- | ---- | ---- | ---- | --3.26M | ---- | ---- | ---- | 200.00%36.38M |
| Net cash from financing operations | -35.82%57.05M | -99.76%275K | 801.08%88.9M | 466.92%112.35M | 43.39%-12.68M | -101.07%-30.62M | -102.98%-22.4M | 590.60%2.86B | 111.23%750.53M | 65.74%414.05M |
| Effect of rate | -65.90%7.22M | -88.90%10.81M | -85.95%21.17M | 244.81%97.39M | 622.90%150.69M | 48.58%-67.25M | -953.61%-28.82M | -1,059.44%-130.78M | -54.52%3.38M | 4.77%13.63M |
| Net Cash | -9.48%-144.1M | 29.21%-388.24M | 71.72%-131.62M | 24.76%-548.45M | -17.68%-465.36M | -129.08%-728.95M | -165.69%-395.44M | 2,230.08%2.51B | 159.35%601.96M | 8.17%107.57M |
| Begining period cash | -27.28%1.01B | -24.59%1.38B | -24.59%1.38B | -30.27%1.83B | -30.27%1.83B | 932.15%2.63B | 932.15%2.63B | 90.68%254.87M | 90.68%254.87M | 530.43%133.66M |
| Cash at the end | -31.73%869.03M | -27.28%1.01B | -16.24%1.27B | -24.59%1.38B | -31.12%1.52B | -30.27%1.83B | 156.49%2.21B | 932.15%2.63B | 130.50%860.2M | 90.68%254.87M |
| Cash balance analysis | ||||||||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
HK
Overall
Symbol
Price
% Chg
No Data
